Chemotherapy-induced Diarrhea Overview
Chemotherapy-induced diarrhea, also called chemotherapy-related diarrhea, is a common problem in cancer patients and is most often described with fluoropyrimidines, irinotecan, and several molecularly targeted agents. It can be debilitating and sometimes life-threatening; hospital admission is frequently needed for adequate supportive care.
&nbsp;
Chemotherapy-induced Diarrhea Epidemiology Insights (2022)
<ul>
<li>The total Incident cases of Chemotherapy-induced Diarrhea in the 7MM were ~1 million in 2022</li>
<li>Lung cancer contributed to the highest number of cases in the US among selected major</li>
<li>Cancers.</li>
<li>In EU4 and the UK, colorectal cancer represented the second-highest number of incident cases in the United</li>
<li>In the US, ~60% of cancer incident cases receive chemotherapy.</li>
<li>Among the total incident cases, ~40% of cases develop Grade &ge;3 Chemotherapy-induced Diarrhea</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/chemotherapy-induced-diarrhea-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Chemotherapy-induced Diarrhea Epidemiology</a> Segmentation in the 7MM from 2019 to 2032
<ul>
<li>Incident Cases of Selected Cancer Types</li>
<li>Total Patients on Chemotherapies by Cancer Types</li>
<li>Incident Cases of Chemotherapy-induced Diarrhea by Selected Cancer Types</li>
<li>Grade-specific Cases of Chemotherapy-induced Diarrhea</li>
<li>Total Treated Cases of Chemotherapy-induced Diarrhea</li>
</ul>
&nbsp;
Chemotherapy-induced Diarrhea Major Treatment Options
<ul>
<li>Loperamide</li>
<li>Octreotide</li>
<li>Other anti-diarrheal therapies</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/chemotherapy-induced-diarrhea-market" target="_blank" rel="noopener noreferrer">Chemotherapy-induced Diarrhea Market</a> Insight (2022)
<ul>
<li>The Chemotherapy-induced Diarrhea Market size was valued&nbsp; ~USD 80 million in the 7MM in 2022</li>
<li>The US accounted for the largest Chemotherapy-induced Diarrhea market size.</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/chemotherapy-induced-diarrhea-pipeline-insights" target="_blank" rel="noopener noreferrer">Chemotherapy-induced Diarrhea Emerging Drugs</a> and Companies
<ul>
<li>MYTESI: Napo Pharmaceuticals (Jaguar Health), and others</li>
</ul>

Chemotherapy Induced Diarrhea Market

Chemotherapy Induced Diarrhea Market Infographics

Chemotherapy Induced Diarrhea Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape